Tandem Diabetes Care

TNDM Small Cap

Healthcare · Medical Devices

Updated: Apr 5, 2026, 17:43 UTC

$18.61

-1.06% today

52W: $9.98 – $29.65

52W Low: $9.98 Position: 43.9% 52W High: $29.65

🔗 Compare Brokers

Key Metrics

P/E Ratio

—

Price-to-Earnings

Forward P/E

—

Forward Price/Earnings

P/S Ratio

1.25x

Price-to-Sales

EV/EBITDA

—

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$1.3B

Market Capitalization

Revenue Growth

2.7%

YoY Revenue Growth

Profit Margin

-20.17%

Net profit margin

ROE

-97.89%

Return on Equity

Beta

1.74

Market sensitivity

Short Interest

21.3%

% of float sold short

Avg. Volume

2,019,914

Average daily volume

Valuation Analysis

Signal

N/A

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

21 analysts

Avg. Price Target

$30.76

+65.3% upside

Target Range

$20.00 – $56.00

About the Company

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy

Sector: Healthcare Industry: Medical Devices Country: United States Employees: 2,500 Exchange: NGM